On September 18, 2024, Cellebrite DI Ltd. announced the redemption of all outstanding public and private placement warrants at $0.10 each, with 99.4% of public warrants exercised for a total of 6,798,440 ordinary shares, leaving no public warrants outstanding. The redemption resulted in the delisting of public warrants from Nasdaq but did not impact the trading of ordinary shares.